Clinical Trial Update: Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing safety and tolerability of ART-123 in combination with FOLFOX and bevacizumab in patients with metastatic colorectal cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• ART-123 (recombinant human soluble thrombomodulin)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 1 | Status: TERMINATED